Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PCSK9”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02634580
What this trial is testing

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4

Who this might be right for
Hypercholesterolemia
Amgen 61
Large-scale testing (Phase 3)Looking for participantsNCT06568471
What this trial is testing

A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia

Who this might be right for
HypercholesterolemiaDyslipidemiasPrimary Hypercholesterolemia+4 more
Hasten Biopharmaceutical Co., Ltd. 210
Large-scale testing (Phase 3)Not Yet RecruitingNCT07174375
What this trial is testing

PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy

Who this might be right for
Acute Ischemic Stroke
Nanfang Hospital, Southern Medical University 478
Testing effectiveness (Phase 2)Ended earlyNCT03004001
What this trial is testing

Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Gloria Vega 3
Testing effectiveness (Phase 2)Study completedNCT07278830
What this trial is testing

A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterolemia and Mixed Dyslipidemia

Who this might be right for
Hypercholesterolemia and Mixed Dyslipidemia
Shenzhen Salubris Pharmaceuticals Co., Ltd. 214
Not applicableLooking for participantsNCT07540741
What this trial is testing

Efficacy and Safety of PCSK9 Inhibitors in Patients With Large-Artery Atherosclerosis (LAA) Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
First Affiliated Hospital of Harbin Medical University 1,000
Post-approval studies (Phase 4)Not Yet RecruitingNCT07819643
What this trial is testing

RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling

Who this might be right for
Atherosclerosis CerebralCarotid PlaqueVulnerable Plaque+1 more
Keqiang Zhao 120
Large-scale testing (Phase 3)Study completedNCT01763918
What this trial is testing

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2

Who this might be right for
Hyperlipidemia
Amgen 331
Post-approval studies (Phase 4)Active Not RecruitingNCT04951856
What this trial is testing

Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI

Who this might be right for
STEMI - ST Elevation Myocardial InfarctionNSTEMI - Non-ST Segment Elevation MI
Assistance Publique - Hôpitaux de Paris 2,166
Large-scale testing (Phase 3)Study completedNCT02189837
What this trial is testing

Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody

Who this might be right for
Primary Hyperlipidemia and Mixed Dyslipidemia
Amgen 89
Not applicableLooking for participantsNCT05430828
What this trial is testing

Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy

Who this might be right for
Hypercholesterolemia
Federico II University 5,000
Not applicableUnknownNCT05624658
What this trial is testing

Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS

Who this might be right for
Dyslipidemias
Samara Regional Cardiology Dispensary 200
Post-approval studies (Phase 4)Looking for participantsNCT07581808
What this trial is testing

Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention

Who this might be right for
HypercholesterolemiaAtherosclerotic Cardiovascular Disease (ASCVD)
University Medical Centre Ljubljana 60
Testing effectiveness (Phase 2)Study completedNCT03933293
What this trial is testing

Evaluate the Safety and Efficacy of the PCSK9 Inhibitor AK102 in Patients With HoFH

Who this might be right for
Homozygous Familial Hypercholesterolemia
Akeso 10
Not applicableStudy completedNCT03139630
What this trial is testing

COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV-Infected Patients

Who this might be right for
HIV SeropositivityDyslipidemiasPCSK9
Franck Boccara 193
Testing effectiveness (Phase 2)Looking for participantsNCT07468630
What this trial is testing

Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma

Who this might be right for
Colon Adenocarcinoma
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 106
Post-approval studies (Phase 4)Looking for participantsNCT06909565
What this trial is testing

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Who this might be right for
Percutaneous Coronary InterventionPeripheral Endovascular Intervention
Duke University 6,000
Large-scale testing (Phase 3)Active Not RecruitingNCT06008756
What this trial is testing

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

Who this might be right for
ArteriosclerosisHypercholesterolaemia
Merck Sharp & Dohme LLC 14,550
Post-approval studies (Phase 4)Looking for participantsNCT05152888
What this trial is testing

The Impact of Pcsk-9 Inhibition on PET CFR in Patients at High CV Risk

Who this might be right for
Stable Coronary Disease
Brigham and Women's Hospital 50
Not applicableStudy completedNCT03110432
What this trial is testing

Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry

Who this might be right for
DyslipoproteinemiasHypercholesterolemia, FamilialFamilial Hypercholesterolemia - Homozygous+1 more
GWT-TUD GmbH 1,695
Next Page